$PODD
INSULET CORP Stock $podd

$podd Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000114519723000039 Filed on May 05, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$396.5M	$358.1M
YoY Change	32.43%	21.23%
Cost Of Revenue	$131.6M	$117.6M
YoY Change	20.62%	37.22%
Gross Profit	$264.9M	$240.5M
YoY Change	39.2%	14.69%
Gross Profit Margin	66.81%	67.16%
Selling, General & Admin	$178.7M	$162.7M
YoY Change	2.47%	26.42%
% of Gross Profit	67.46%	67.65%
Research & Development	$55.10M	$50.10M
YoY Change	29.34%	16.24%
% of Gross Profit	20.8%	20.83%
Depreciation & Amortization	$18.10M	$17.20M
YoY Change	14.56%	12.42%
% of Gross Profit	6.83%	7.15%
Operating Expenses	$233.8M	$212.8M
YoY Change	448.83%	393.74%
Operating Profit	$31.10M	$27.70M
YoY Change	-216.48%	-26.91%
Interest Expense	$9.700M	$9.400M
YoY Change	6.59%	4.44%
% of Operating Profit	31.19%	33.94%
Other Income/Expense, Net	-$200.0K	-$200.0K
YoY Change	-81.82%	-166.67%
Pretax Income	$28.50M	$24.60M
YoY Change	-178.95%	-16.04%
Income Tax	$1.200M	$800.0K
% Of Pretax Income	4.21%	3.25%
Net Earnings	$27.30M	$23.80M
YoY Change	-178.0%	-14.39%
Net Earnings / Revenue	6.89%	6.65%
Basic Earnings Per Share	$0.39	$0.34
Diluted Earnings Per Share	$0.39	$0.34
COMMON SHARES
Basic Shares Outstanding	69.70M shares	69.54M shares
Diluted Shares Outstanding	70.14M shares	70.10M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$541.4M	$518.7M
YoY Change	-17.65%	-26.79%
Cash & Equivalents	$660.1M	$635.9M
Short-Term Investments
Other Short-Term Assets	$218.3M	$208.0M
YoY Change	75.06%	185.71%
Inventory	$411.3M	$386.1M
Prepaid Expenses
Receivables	$250.5M	$159.6M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.422B	$1.330B
YoY Change	8.59%	3.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$601.5M	$596.6M
YoY Change	12.26%	10.85%
Goodwill	$51.70M	$51.70M
YoY Change	-0.19%	-0.19%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$211.6M	$210.6M
YoY Change	30.7%	49.36%
Total Long-Term Assets	$964.3M	$959.1M
YoY Change	19.85%	22.37%
TOTAL ASSETS
Total Short-Term Assets	$1.422B	$1.330B
Total Long-Term Assets	$964.3M	$959.1M
Total Assets	$2.386B	$2.289B
YoY Change	12.87%	10.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$107.5M	$85.90M
YoY Change	87.94%	64.56%
Accrued Expenses	$271.1M	$263.6M
YoY Change	40.83%	94.11%
Deferred Revenue	$19.40M	$22.20M
YoY Change	207.94%	484.21%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$29.20M	$27.80M
YoY Change	11.03%	8.17%
Total Short-Term Liabilities	$425.0M	$383.3M
YoY Change	52.17%	78.28%
LONG-TERM LIABILITIES
Long-Term Debt	$1.369B	$1.369B
YoY Change	-1.2%	-1.56%
Other Long-Term Liabilities	$38.30M	$34.20M
YoY Change	42.91%	101.18%
Total Long-Term Liabilities	$1.407B	$1.403B
YoY Change	-0.36%	-0.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$425.0M	$383.3M
Total Long-Term Liabilities	$1.407B	$1.403B
Total Liabilities	$1.832B	$1.786B
YoY Change	8.31%	10.1%
SHAREHOLDERS EQUITY
Retained Earnings	-$533.2M	-$560.5M
YoY Change	-10.55%	-0.11%
Common Stock	$100.0K	$100.0K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$553.9M	$502.8M
YoY Change
Total Liabilities & Shareholders Equity	$2.386B	$2.289B
YoY Change	12.87%	10.63%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$27.30M	$23.80M
YoY Change	-178.0%	-14.39%
Depreciation, Depletion And Amortization	$18.10M	$17.20M
YoY Change	14.56%	12.42%
Cash From Operating Activities	$44.00M	$500.0K
YoY Change	73.91%	-103.65%
INVESTING ACTIVITIES
Capital Expenditures	$18.10M	$10.50M
YoY Change	-194.76%	-17.97%
Acquisitions
YoY Change
Other Investing Activities	-$5.000M	-$5.000M
YoY Change	78.57%	-83.87%
Cash From Investing Activities	-$23.10M	-$42.10M
YoY Change	5.48%	-10.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.200M	-$12.10M
YoY Change	-300.0%	-40.39%
NET CHANGE
Cash From Operating Activities	44.00M	$500.0K
Cash From Investing Activities	-23.10M	-$42.10M
Cash From Financing Activities	3.200M	-$12.10M
Net Change In Cash	24.10M	-$53.80M
YoY Change	1238.89%	-33.99%
FREE CASH FLOW
Cash From Operating Activities	$44.00M	$500.0K
Capital Expenditures	$18.10M	$10.50M
Free Cash Flow	$25.90M	-$10.00M
YoY Change	-41.67%	-62.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001145197
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-33462
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	INSULET CORPORATION
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3523891
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	100 Nagog Park
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Acton
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01720
CY2023Q1	dei	City Area Code CityAreaCode	978
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	600-7000
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001 Par Value Per Share
CY2023Q1	dei	Trading Symbol TradingSymbol	PODD
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	69695828	shares
CY2023Q1	podd	Cash Cash Equivalents And Restricted Cash Current CashCashEquivalentsAndRestrictedCashCurrent	620700000	usd
CY2022Q4	podd	Cash Cash Equivalents And Restricted Cash Current CashCashEquivalentsAndRestrictedCashCurrent	674700000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3100000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2500000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	159600000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	140900000	usd
CY2023Q1	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	57600000	usd
CY2022Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	64700000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	386100000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	346800000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	106000000.0	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	86900000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1330000000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1314000000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	27800000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	596600000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	599900000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	100200000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	75500000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	51700000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	51700000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	210600000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	210000000.0	usd
CY2023Q1	us-gaap	Assets Assets	2289100000	usd
CY2022Q4	us-gaap	Assets Assets	2251100000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	85900000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	30800000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	263600000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	301000000.0	usd
CY2023Q1	podd	Accrued Expenses And Other Current Liabilities Related Parties AccruedExpensesAndOtherCurrentLiabilitiesRelatedParties	6000000.0	usd
CY2022Q4	podd	Accrued Expenses And Other Current Liabilities Related Parties AccruedExpensesAndOtherCurrentLiabilitiesRelatedParties	5400000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	27500000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	383300000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	364700000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1368800000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1374300000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	34200000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	35700000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1786300000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1774700000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	69694363	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	69694363	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	69511286	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	69511286	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	100000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	100000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1047300000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1040600000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-560500000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-584300000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	15900000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	20000000.0	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	502800000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	476400000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2289100000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2251100000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	261300000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	247000000.0	usd
CY2023Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	96800000	usd
CY2022Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	48400000	usd
CY2023Q1	us-gaap	Revenues Revenues	358100000	usd
CY2022Q1	us-gaap	Revenues Revenues	295400000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	117600000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	85700000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	240500000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	209700000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	50100000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	43100000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	162700000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	128700000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	27700000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	37900000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2900000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-8900000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-200000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	300000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	24600000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	29300000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1500000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	23800000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	27800000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69583000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69254000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70096000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69858000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	23800000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	27800000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1700000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3700000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	-5800000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent	18100000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4100000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	14400000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	19700000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	42200000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	476400000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6000000.0	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12100000	usd
CY2023Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-11400000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	23800000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4100000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	502800000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	556300000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1100000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9500000	usd
CY2022Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-15300000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	27800000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	14400000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	446700000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	23800000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	27800000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17200000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15300000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	12100000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	9500000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1500000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1500000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1200000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	800000	usd
CY2023Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	700000	usd
CY2022Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-600000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19200000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	19900000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-7100000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	10100000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	38200000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	13000000.0	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	20700000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	6400000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	51500000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	14700000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-35900000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-33700000	usd
CY2023Q1	podd	Increase Decrease In Accrued Liabilities And Other Operating Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilitiesRelatedParties	-600000	usd
CY2022Q1	podd	Increase Decrease In Accrued Liabilities And Other Operating Liabilities Related Parties IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilitiesRelatedParties	400000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	500000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13700000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10500000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12800000	usd
CY2023Q1	us-gaap	Payments For Software PaymentsForSoftware	1500000	usd
CY2022Q1	us-gaap	Payments For Software PaymentsForSoftware	3100000	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	25100000	usd
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	3000000.0	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	26000000.0	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2000000.0	usd
CY2022Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	5000000.0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-42100000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-46900000	usd
CY2023Q1	podd	Repayment Of Equipment Financings RepaymentOfEquipmentFinancings	4800000	usd
CY2022Q1	podd	Repayment Of Equipment Financings RepaymentOfEquipmentFinancings	4300000	usd
CY2023Q1	podd	Repayments Of Term Loan RepaymentsOfTermLoan	1300000	usd
CY2022Q1	podd	Repayments Of Term Loan RepaymentsOfTermLoan	1300000	usd
CY2023Q1	podd	Repayment Of Mortgage RepaymentOfMortgage	600000	usd
CY2022Q1	podd	Repayment Of Mortgage RepaymentOfMortgage	500000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6000000.0	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1100000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	11400000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	15300000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12100000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-20300000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-100000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-600000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-53800000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-81500000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	689700000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	806400000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	635900000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	724900000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5100000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	7800000	usd
CY2023Q1	podd	Purchases Of Developed Software Included In Accounts Payable And Accrued Expenses PurchasesOfDevelopedSoftwareIncludedInAccountsPayableAndAccruedExpenses	800000	usd
CY2022Q1	podd	Purchases Of Developed Software Included In Accounts Payable And Accrued Expenses PurchasesOfDevelopedSoftwareIncludedInAccountsPayableAndAccruedExpenses	2800000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	100000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1600000	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2000000	usd
CY2023Q1	us-gaap	Other Investment Not Readily Marketable Fair Value OtherInvestmentNotReadilyMarketableFairValue	10700000	usd
CY2022Q4	us-gaap	Other Investment Not Readily Marketable Fair Value OtherInvestmentNotReadilyMarketableFairValue	8700000	usd
CY2023Q1	us-gaap	Revenues Revenues	358100000	usd
CY2022Q1	us-gaap	Revenues Revenues	295400000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	22200000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	16100000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1700000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1600000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	23900000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	17700000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	9900000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1300000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	16000000.0	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	15200000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	33000000.0	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	31300000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	49000000.0	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	46500000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	4000000	usd
CY2022Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	3400000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	500000	usd
CY2023Q1	podd	Cash Cash Equivalents And Restricted Cash Current CashCashEquivalentsAndRestrictedCashCurrent	620700000	usd
CY2022Q4	podd	Cash Cash Equivalents And Restricted Cash Current CashCashEquivalentsAndRestrictedCashCurrent	674700000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	15200000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	15000000.0	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	635900000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	689700000	usd
CY2023Q1	podd	Cash And Cash Equivalents Net Cash Position CashAndCashEquivalentsNetCashPosition	3100000	usd
CY2023Q1	podd	Cash And Cash Equivalents Gross Cash Position CashAndCashEquivalentsGrossCashPosition	100300000	usd
CY2023Q1	podd	Cash Borrowings CashBorrowings	97200000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	159600000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	140900000	usd
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	94200000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	79100000	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	112300000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	84200000	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	179600000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	183500000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	386100000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	346800000	usd
CY2023Q1	podd	Excess And Obsolete Inventory Charge ExcessAndObsoleteInventoryCharge	2200000	usd
CY2022Q1	podd	Excess And Obsolete Inventory Charge ExcessAndObsoleteInventoryCharge	1100000	usd
CY2023Q1	podd	Capitalized Computer Software Gross Current CapitalizedComputerSoftwareGrossCurrent	20000000.0	usd
CY2022Q4	podd	Capitalized Computer Software Gross Current CapitalizedComputerSoftwareGrossCurrent	18000000.0	usd
CY2023Q1	podd	Capitalized Computer Software Gross Noncurrent CapitalizedComputerSoftwareGrossNoncurrent	95000000.0	usd
CY2022Q4	podd	Capitalized Computer Software Gross Noncurrent CapitalizedComputerSoftwareGrossNoncurrent	87100000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	115000000.0	usd
CY2022Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	105100000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	21400000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	17100000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	93600000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	88000000.0	usd
CY2023Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	4300000	usd
CY2022Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1300000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	51700000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	51700000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	143500000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	43300000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	100200000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	116400000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	40900000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	75500000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2400000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1800000	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	25100000	usd
CY2023Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P11Y
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	55200000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	95900000	usd
CY2023Q1	podd	Accrued Rebates Current AccruedRebatesCurrent	82600000	usd
CY2022Q4	podd	Accrued Rebates Current AccruedRebatesCurrent	69600000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	35000000.0	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	57300000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	33200000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	27500000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	57600000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	50700000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	263600000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	301000000.0	usd
CY2022Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	62100000	usd
CY2021Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	6800000	usd
CY2023Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	5500000	usd
CY2022Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	3000000.0	usd
CY2023Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-8000000.0	usd
CY2022Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	0	usd
CY2023Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	20400000	usd
CY2022Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	2900000	usd
CY2023Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	39200000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1368800000	usd
CY2022Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	6900000	usd
CY2022Q4	podd	Number Of Voluntary Medical Device Correction Notices Issued NumberOfVoluntaryMedicalDeviceCorrectionNoticesIssued	2	notice
CY2023Q1	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-8000000	usd
CY2023Q1	podd	Standard And Extended Product Warranty Accrual Related To Medical Device Correction Notices StandardAndExtendedProductWarrantyAccrualRelatedToMedicalDeviceCorrectionNotices	31000000.0	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	7300000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	7600000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	14000000.0	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	15000000.0	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	1396600000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	1401800000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	27800000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	27500000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1374300000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12100000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9500000	usd
CY2023Q1	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	400000	usd
CY2022Q1	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	400000	usd
CY2023Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	300000	usd
CY2023Q1	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	4400000	usd
CY2022Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	13900000	usd
CY2022Q1	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-500000	usd
CY2023Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	8300000	usd
CY2022Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	7900000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	400000	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	400000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1100000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1100000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	9400000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	9000000.0	usd
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	6500000	usd
CY2022Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	100000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-2900000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-8900000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.034
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.051
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69583000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69254000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	70096000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69858000	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3921000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3869000	shares

Files In Submission

Name	View Source	Status
podd-20230331_lab.xml	Edgar Link	unprocessable
0001145197-23-000039-index-headers.html	Edgar Link	pending
0001145197-23-000039-index.html	Edgar Link	pending
0001145197-23-000039.txt	Edgar Link	pending
0001145197-23-000039-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
podd-20230331.htm	Edgar Link	pending
podd-20230331.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
podd-20230331_cal.xml	Edgar Link	unprocessable
podd-20230331_def.xml	Edgar Link	unprocessable
podd-exx311x2023x03x31_10q.htm	Edgar Link	pending
podd-exx312x2023x03x31_10q.htm	Edgar Link	pending
podd-exx321x2023x03x31_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
podd-20230331_pre.xml	Edgar Link	unprocessable
podd-20230331_htm.xml	Edgar Link	completed
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PODD
INSULET CORP Stock $podd

2023 Q2 Form 10-Q Financial Statement

#000114519723000039 Filed on May 05, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODD INSULET CORP Stock $podd

2023 Q2 Form 10-Q Financial Statement

#000114519723000039 Filed on May 05, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODD
INSULET CORP Stock $podd